A Novel Device for the Treatment of Postural Hypotension - a Signal of Effectiveness Study.
- Conditions
- Orthostatic Hypotension
- Registration Number
- NCT06039410
- Lead Sponsor
- Isotech Ltd
- Brief Summary
The goal of this clinical trial is to test a novel medical device (ISO-101) in patients diagnosied with orthostatic hypotension. The main question\[s\] it aims to answer are:
* to determine whether the ISO-101 device demonstrates a signal of efficacy in people with OH and whether it is worthy of further clinical evaluation.
* Assess the safety and performance of the ISO-101 device in patients with orthostatic hypotension.
Participants will use the device under controlled conditions and have the following parameters measured before and after standing up:
* blood pressure
* markers of peripheal vascular resistence
* sympathetic nervous system activity measure before and after standing up
- Detailed Description
This is a proof of principle study aimed at evaluating if there is a signal of efficacy from use of the ISO-101 device in people with orthostatic hypotension. The study is a single centre, unblinded, pre-post study. All participants will act as their own control, and all will receive the intervention.The primary objective is to determine whether the ISO-101 device demonstrates a signal of efficacy in people with OH and whether it is worthy of further clinical evaluation.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 30
- Willing and able to give informed consent for participation in the study
- Adults aged over 18 years with a clinical diagnosis of orthostatic hypotension
- A drop in systolic BP of ≥20 mmHg (with or without a drop in diastolic BP ≥10 mmHg) within 3 minutes of standing up from a supine position
- Able to stand up from a supine position (with assistance if required)
- Cognitively unable to follow research procedures
- Physically unable to use the ISO-101 device (e.g., unilateral arm weakness due to stroke)
- Acute or reversible cause of OH (e.g., haemorrhage or sepsis)
- Current pregnancy
- Participants on insulin (participants will be asked to refrain from breakfast on the morning of their assessment)
- Resting supine systolic BP ≥180 or diastolic ≥110 mmHg
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Adverse Events From date of enrollment until end of study completion (24 hours) Adverse events
Blood pressure (mmHg) From date of enrollment until end of study completion (24 hours) The change in resting BP, standing BP and postural BP drop during and immediately after using the device.
- Secondary Outcome Measures
Name Time Method Cardiovascular variablity From date of enrollment until end of study completion (24 hours) Changes in peripheral vascular resistance (dyn\*s\*m2/cm5) and sympathetic nervous system activity (heart rate variability)
Post study participant questionaire From date of enrollment until end of study completion (24 hours) 7 point Likert Scale covering the following domains; usefulness, ease of use, ease of learning, satisfaction and intention to use
Investigator feedback From date of enrollment until end of study completion (24 hours) Global impression score
Blood pressure From date of enrollment until end of study completion (24 hours) Magnitude and duration of treatment effect on blood pressure
Erganomics From date of enrollment until end of study completion (24 hours) Number of participants able to effectively use the device
Trial Locations
- Locations (1)
Falls and Syncope Service, Older People's Medicine, The Newcastle upon Tyne Hospitals NHS Foundation Trust
🇬🇧Newcastle Upon Tyne, United Kingdom
Falls and Syncope Service, Older People's Medicine, The Newcastle upon Tyne Hospitals NHS Foundation Trust🇬🇧Newcastle Upon Tyne, United KingdomDr Frith, MBChB FRCP PhDContactjames.frith@newcastle.ac.uk